Bank of Montreal
KRON

Bank of Montreal’s Kronos Bio KRON Stock Holding History

Bank of Montreal’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-251,965
Closed -$947 – 4254
2022
Q2 		$947 Buy
+251,965
New +$1.14M ﹤0.01% 2343
2021
Q2 		– Sell
-451
Closed -$12K – 4334
2021
Q1 		$12K Sell
451
-1,830
-80% -$53.6K ﹤0.01% 4277
2020
Q4 		$73K Buy
+2,281
New +$71.6K ﹤0.01% 3747

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Bank of Montreal's KRON Position: Q3 2022 in Review

Bank of Montreal sold out of Kronos Bio (KRON) in Q3 2022, closing a stake of 251,965 shares — an estimated $947 sold.

Bank of Montreal first reported a position in KRON in Q4 2020 and held it in 3 quarters. The position peaked at $73K in Q4 2020. 96 funds tracked by Wall St. Rank hold KRON as of Q3 2022.

  • Bank of Montreal reported no remaining Kronos Bio position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 251,965 Kronos Bio shares in Q3 2022, an estimated $947.
  • Bank of Montreal first reported a position in Kronos Bio in Q4 2020 and held it in 3 quarters.
  • Bank of Montreal's Kronos Bio position peaked at $73K in Q4 2020.
  • 96 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.